Thyroid disorder Board decisions

The Veteran's claims for hepatitis C, hyperthyroidism, and Type 2 diabetes mellitus have been granted. The appeals for service connection for a lung disability, chronic fatigue syndrome, brain fog, hypertension, and osteoarthritis are dismissed or remanded.

The Veteran's effective dates for the grants of service connection and increased ratings are set to April 18, 2021.

The Veteran's initial compensable evaluation for service-connected hypothyroidism was denied.,The Veteran's bladder cancer, in remission, is being remanded for further evaluation.

The Board dismissed the appeal as to service connection for a thyroid condition because the appellant requested withdrawal of the appeal.

The appeal seeking service connection for hypertension prior to August 10, 2022 is dismissed. Service connection for hemorrhoids and a skin disorder are denied. The appeals for service connection for an acquired psychiatric disorder (PTSD and unspecified depressive disorder), colon polyps, and hyperthyroidism are remanded.

The Board has granted service connection for papillary thyroid cancer, finding that it initially manifested during active duty and is related to the Veteran's in-service duties as an emergency welder.

The Board has determined that the Veteran's thyroid disorder, including hyperthyroidism and hypothyroidism, manifested within one year of her discharge from her third period of active duty service. Service connection is granted.

The Board has decided to remand the case due to a duty to assist error and an issue related to the Veteran's exposure to Agent Orange during service. The claim for service connection is being reviewed again as there was not enough evidence provided at the time of the April 2023 rating decision.

The Board denied the Veteran's claim for an earlier effective date for service connection of hypothyroidism and also denied his request for a higher initial rating. The Board found that there was no evidence to support direct service connection or any other theory of entitlement prior to the enactment of the PACT Act, which granted presumptive service connection based on herbicide exposure.

The Board has determined that additional development is needed for the Veteran's claim of entitlement to an initial compensable rating for hypothyroidism, and thus remands the case back to the RO for further action.

The Board has determined that earlier effective dates for service connection are not warranted for the Veteran's claimed conditions. The issues of initial disability ratings and an initial compensable rating have been REMANDED for further action.

The Board has remanded the Veteran's claims for obstructive sleep apnea, hypertension, hypothyroidism, and dry eyes due to insufficient medical opinions regarding their etiology.

The Veteran's claims for service connection were granted effective July 3, 2018. The effective dates are based on the date of receipt of an intent to file a claim and not necessarily when the conditions were first experienced or diagnosed.

The Board has decided to remand the case due to a duty-to-assist error regarding when the Veteran's hypothyroidism first manifested.

The Board has granted service connection for prostate cancer and coronary arteriosclerosis, but has remanded the cases of urinary bladder cancer and hypothyroidism due to lack of evidence.

The Veteran withdrew his appeal regarding an earlier effective date for service connection of hypothyroidism s/p ablation therapy, so the case is dismissed.

The Veteran's initial compensable rating for hypothyroidism is being remanded due to a duty-to-assist error involving non-VA treatment records. The AOJ will obtain these records and associate them with the claims file.

The Veteran's claims for service connection for a heart disorder and hypothyroidism were denied in September 2021. The appeals for these issues have been dismissed as the Veteran did not timely file a VA Form 10182 within one year of being notified of the denial.

The Board denied the Veteran's claim for service connection for hyperparathyroidism, finding that his condition is not causally or etiologically related to his active-duty service. The evidence did not support a presumption of exposure to herbicide agents as defined by VA regulation.

The Board has granted service connection for prostate cancer and coronary arteriosclerosis, but has remanded the cases of urinary bladder cancer and hypothyroidism due to lack of evidence.